Compare $PVLA vs $SRPT | Chartloom

Compare

$PVLA vs $SRPT

Palvella Therapeutics Inc · Sarepta Therapeutics Inc

PVLA

Palvella Therapeutics Inc

SRPT

Sarepta Therapeutics Inc

Compare $PVLA vs $SRPT

Comparing Palvella Therapeutics Inc and Sarepta Therapeutics Inc

PVLAPalvella Therapeutics Inc

SRPTSarepta Therapeutics Inc

PVLAPalvella Therapeutics Inc

Market cap

$1.99B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-97.2%

YTD performance

38.4%

52W performance

85.4%

FCF yield

-1.8%

SRPTSarepta Therapeutics Inc

Market cap

$1.88B

P/E (TTM)

—

Forward P/E (NTM)

46.80x

Forward P/S (NTM)

1.31x

Rev growth (TTM)

-20.4%

YTD performance

-16.2%

52W performance

-23.7%

FCF yield

4.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PVLA

SRPT

Detailed metrics comparison

PVLA

Palvella Therapeutics Inc

SRPT

Sarepta Therapeutics Inc

Market Cap

PVLA$1.99B

SRPT$1.88B

Enterprise Value

PVLA$1.82B

SRPT$2.16B

Price

PVLA$138.77

SRPT$17.85

P/E Ratio

PVLAN/A

SRPTN/A

P/S Ratio

PVLA46.64x

SRPT0.95x

EV/Sales

PVLA0.00x

SRPT1.09x

EV/EBITDA

PVLA0.00x

SRPT12.13x

P/B Ratio

PVLA8.80x

SRPT1.21x

P/FCF Ratio

PVLAN/A

SRPT25.00x

EV/FCF

PVLA-49.96x

SRPT28.66x

PEG Ratio

PVLAN/A

SRPTN/A

Forward P/E (NTM)

PVLAN/A

SRPT46.80x

Forward P/S (NTM)

PVLAN/A

SRPT1.31x

Revenue (TTM)

PVLA$0

SRPT$1.97B

Revenue Growth (YoY)

PVLA-97.2%

SRPT-20.4%

Forward Rev Growth

PVLA287.4%

SRPT-23.2%

Gross Margin (TTM)

PVLA0.0%

SRPT67.5%

Operating Margin (TTM)

PVLA0.0%

SRPT0.0%

EBITDA Margin (TTM)

PVLA0.0%

SRPT7.5%

Net Margin (TTM)

PVLA0.0%

SRPT-6.9%

FCF Margin (TTM)

PVLAN/A

SRPT3.8%

Net Income (TTM)

PVLA$-62M

SRPT$-137M

FCF (TTM)

PVLA$-37M

SRPT$75M

EPS (TTM)

PVLA-$4.30

SRPT-$1.30

ROE (TTM)

PVLA-4784.0%

SRPT-996.0%

ROA (TTM)

PVLA-3833.0%

SRPT-414.0%

ROIC (TTM)

PVLA-4172.0%

SRPT-605.0%

Cash

PVLA$188M

SRPT$571M

Debt

PVLA$22M

SRPT$848M

Net Cash/Debt

PVLA$166M

SRPT$-276M

Current Ratio (TTM)

PVLA21.18x

SRPT4.42x

Quick Ratio (TTM)

PVLA21.01x

SRPT2.57x

Debt/Equity (TTM)

PVLA0.10x

SRPT0.55x

Debt/Assets (TTM)

PVLA0.0%

SRPT0.0%

Interest Coverage (TTM)

PVLAN/A

SRPTN/A

Net Debt/EBITDA (TTM)

PVLA0.00x

SRPT0.00x

Beta

PVLA-0.19

SRPT0.46

52W Performance

PVLA85.4%

SRPT-23.7%

YTD Performance

PVLA38.4%

SRPT-16.2%

% from 52W High

PVLA-14.0%

SRPT-27.7%

% from 52W Low

PVLA110.5%

SRPT21.6%

Asset Turnover (TTM)

PVLA0.76x

SRPT0.60x

FCF Yield (TTM)

PVLA-1.8%

SRPT4.0%

Earnings Yield (TTM)

PVLA-3.1%

SRPT-7.3%

Dividend Yield (TTM)

PVLAN/A

SRPTN/A

Rule of 40

PVLA-97.2

SRPT-16.6

EV/GP/RG

PVLAN/A

SRPTN/A

Ticker research

View PVLA research View SRPT research

Metric	PVLA Palvella Therapeutics Inc	SRPT Sarepta Therapeutics Inc
Market & Valuation
Market Cap	$1.99B	$1.88B
Enterprise Value	$1.82B	$2.16B
Price	$138.77	$17.85
P/E Ratio	N/A	N/A
P/S Ratio	46.64x	0.95x
EV/Sales	0.00x	1.09x
EV/EBITDA	0.00x	12.13x
P/B Ratio	8.80x	1.21x
P/FCF Ratio	N/A	25.00x
EV/FCF	-49.96x	28.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	46.80x
Forward P/S (NTM)	N/A	1.31x
Revenue & Growth
Revenue (TTM)	$0	$1.97B
Revenue Growth (YoY)	-97.2%	-20.4%
Forward Rev Growth	287.4%	-23.2%
Profitability
Gross Margin (TTM)	0.0%	67.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	7.5%
Net Margin (TTM)	0.0%	-6.9%
FCF Margin (TTM)	N/A	3.8%
Net Income (TTM)	$-62M	$-137M
FCF (TTM)	$-37M	$75M
EPS (TTM)	-$4.30	-$1.30
ROE (TTM)	-4784.0%	-996.0%
ROA (TTM)	-3833.0%	-414.0%
ROIC (TTM)	-4172.0%	-605.0%
Financial Health
Cash	$188M	$571M
Debt	$22M	$848M
Net Cash/Debt	$166M	$-276M
Current Ratio (TTM)	21.18x	4.42x
Quick Ratio (TTM)	21.01x	2.57x
Debt/Equity (TTM)	0.10x	0.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.19	0.46
52W Performance	85.4%	-23.7%
YTD Performance	38.4%	-16.2%
% from 52W High	-14.0%	-27.7%
% from 52W Low	110.5%	21.6%
Efficiency & Yields
Asset Turnover (TTM)	0.76x	0.60x
FCF Yield (TTM)	-1.8%	4.0%
Earnings Yield (TTM)	-3.1%	-7.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-97.2	-16.6
EV/GP/RG	N/A	N/A
Ticker research	View PVLA research	View SRPT research

Valuation

P/S Ratio

SRPT

0.95x

PVLA

46.64x

EV/FCF

PVLA

-49.96x

SRPT

28.66x

Growth & revenue

Revenue Growth TTM

SRPT

-20.4%

PVLA

-97.2%

Forward Revenue Growth

PVLA

287.4%

SRPT

-23.2%

Profitability & performance

Gross Margin

SRPT

67.5%

PVLA

0.0%

ROE

SRPT

-996.0%

PVLA

-4784.0%

FCF Yield %

SRPT

4.0%

PVLA

-1.8%

52-Week Performance

PVLA

85.4%

SRPT

-23.7%

Detailed metrics comparison

PVLA

Palvella Therapeutics Inc

SRPT

Sarepta Therapeutics Inc

Market Cap

PVLA$1.99B

SRPT$1.88B

Enterprise Value

PVLA$1.82B

SRPT$2.16B

Price

PVLA$138.77

SRPT$17.85

P/E Ratio

PVLAN/A

SRPTN/A

P/S Ratio

PVLA46.64x

SRPT0.95x

EV/Sales

PVLA0.00x

SRPT1.09x

EV/EBITDA

PVLA0.00x

SRPT12.13x

P/B Ratio

PVLA8.80x

SRPT1.21x

P/FCF Ratio

PVLAN/A

SRPT25.00x

EV/FCF

PVLA-49.96x

SRPT28.66x

PEG Ratio

PVLAN/A

SRPTN/A

Forward P/E (NTM)

PVLAN/A

SRPT46.80x

Forward P/S (NTM)

PVLAN/A

SRPT1.31x

Revenue (TTM)

PVLA$0

SRPT$1.97B

Revenue Growth (YoY)

PVLA-97.2%

SRPT-20.4%

Forward Rev Growth

PVLA287.4%

SRPT-23.2%

Gross Margin (TTM)

PVLA0.0%

SRPT67.5%

Operating Margin (TTM)

PVLA0.0%

SRPT0.0%

EBITDA Margin (TTM)

PVLA0.0%

SRPT7.5%

Net Margin (TTM)

PVLA0.0%

SRPT-6.9%

FCF Margin (TTM)

PVLAN/A

SRPT3.8%

Net Income (TTM)

PVLA$-62M

SRPT$-137M

FCF (TTM)

PVLA$-37M

SRPT$75M

EPS (TTM)

PVLA-$4.30

SRPT-$1.30

ROE (TTM)

PVLA-4784.0%

SRPT-996.0%

ROA (TTM)

PVLA-3833.0%

SRPT-414.0%

ROIC (TTM)

PVLA-4172.0%

SRPT-605.0%

Cash

PVLA$188M

SRPT$571M

Debt

PVLA$22M

SRPT$848M

Net Cash/Debt

PVLA$166M

SRPT$-276M

Current Ratio (TTM)

PVLA21.18x

SRPT4.42x

Quick Ratio (TTM)

PVLA21.01x

SRPT2.57x

Debt/Equity (TTM)

PVLA0.10x

SRPT0.55x

Debt/Assets (TTM)

PVLA0.0%

SRPT0.0%

Interest Coverage (TTM)

PVLAN/A

SRPTN/A

Net Debt/EBITDA (TTM)

PVLA0.00x

SRPT0.00x

Beta

PVLA-0.19

SRPT0.46

52W Performance

PVLA85.4%

SRPT-23.7%

YTD Performance

PVLA38.4%

SRPT-16.2%

% from 52W High

PVLA-14.0%

SRPT-27.7%

% from 52W Low

PVLA110.5%

SRPT21.6%

Asset Turnover (TTM)

PVLA0.76x

SRPT0.60x

FCF Yield (TTM)

PVLA-1.8%

SRPT4.0%

Earnings Yield (TTM)

PVLA-3.1%

SRPT-7.3%

Dividend Yield (TTM)

PVLAN/A

SRPTN/A

Rule of 40

PVLA-97.2

SRPT-16.6

EV/GP/RG

PVLAN/A

SRPTN/A

Ticker research

View PVLA research View SRPT research

Metric	PVLA Palvella Therapeutics Inc	SRPT Sarepta Therapeutics Inc
Market & Valuation
Market Cap	$1.99B	$1.88B
Enterprise Value	$1.82B	$2.16B
Price	$138.77	$17.85
P/E Ratio	N/A	N/A
P/S Ratio	46.64x	0.95x
EV/Sales	0.00x	1.09x
EV/EBITDA	0.00x	12.13x
P/B Ratio	8.80x	1.21x
P/FCF Ratio	N/A	25.00x
EV/FCF	-49.96x	28.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	46.80x
Forward P/S (NTM)	N/A	1.31x
Revenue & Growth
Revenue (TTM)	$0	$1.97B
Revenue Growth (YoY)	-97.2%	-20.4%
Forward Rev Growth	287.4%	-23.2%
Profitability
Gross Margin (TTM)	0.0%	67.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	7.5%
Net Margin (TTM)	0.0%	-6.9%
FCF Margin (TTM)	N/A	3.8%
Net Income (TTM)	$-62M	$-137M
FCF (TTM)	$-37M	$75M
EPS (TTM)	-$4.30	-$1.30
ROE (TTM)	-4784.0%	-996.0%
ROA (TTM)	-3833.0%	-414.0%
ROIC (TTM)	-4172.0%	-605.0%
Financial Health
Cash	$188M	$571M
Debt	$22M	$848M
Net Cash/Debt	$166M	$-276M
Current Ratio (TTM)	21.18x	4.42x
Quick Ratio (TTM)	21.01x	2.57x
Debt/Equity (TTM)	0.10x	0.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.19	0.46
52W Performance	85.4%	-23.7%
YTD Performance	38.4%	-16.2%
% from 52W High	-14.0%	-27.7%
% from 52W Low	110.5%	21.6%
Efficiency & Yields
Asset Turnover (TTM)	0.76x	0.60x
FCF Yield (TTM)	-1.8%	4.0%
Earnings Yield (TTM)	-3.1%	-7.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-97.2	-16.6
EV/GP/RG	N/A	N/A
Ticker research	View PVLA research	View SRPT research